![What do we learn from the COPE study? [COPE: COVID-19 in Older PEople]](https://frailty.net/wp-content/uploads/Covid-2.jpg "What do we learn from the COPE <br> study? [COPE: COVID-19 <br>in Older PEople]")
Frailty news
Conferences, literature reviews, media reports … All news items >
Frailty learning center
Guidelines, algorithms, clinical cases, webcasts… See all >
Frailty toolkit
Slide library, diagnostic tools used in Frailty care… Diagnostic tools >
SPCC task force raises awareness of malnutrition and cachexia in cancer patients
The urgent need for better recognition of malnutrition and cachexia in cancer patients was highlighted by the Sharing Progress in Cancer Care (SPCC) task force on Nutrition and Cachexia in Cancer Patients, held as a virtual meeting on June 22, 2020, with 13 stakeholders across Europe …
ICFSR 2020 – video replay
International Conference on Frailty and Sarcopenia Research
Event: ICFSR 2020, Toulouse, France
Length: Over 20 hrs of video recordings
The 10th International Conference on Frailty and Sarcopenia Research (ICFSR 2020) took place in Toulouse, France in March 2020. All presentations are now available with 20+ hours of video plus slides and additional resources. read more…
A self-reported screening tool for detecting community-dwelling older persons with frailty syndrome in the absence of mobility disability: the FiND questionnaire
The detection of frail older individuals living in the community represents a crucial preliminary step in the development of effective prevention against disability …
Bimagrumab vs Optimised Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial
Sarcopenia is an important health concern in elderly adults because it is associated with adverse outcomes such as falls, disability, and mortality. Recently, international treatment guidelines for sarcopenia recommend an improved nutritional status, habitual physical activity, and exercise as first-line therapy …
PPARs and microbiota in skeletal muscle
Skeletal muscle wasting occurs in many diseases and during aging. Muscle wasting is often accompanied by chronic low-grade inflammation associated to inter- and intra-muscular fat deposition. During aging, muscle wasting is advanced due to increased …
ICFSR task force perspective on biomarkers for sarcopenia and frailty
Biomarkers of frailty and sarcopenia are very important to deepen understanding, as well as to promote the development of new diagnostic tools and effective treatments. The ICFSR Task Force – a group of academic and industry scientists from around the world – met …
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
The urgent need for better recognition of malnutrition and cachexia in cancer patients was highlighted by the Sharing Progress in Cancer Care (SPCC) task force on Nutrition and Cachexia in Cancer Patients, held as a virtual meeting on June 22, 2020, with 13 stakeholders from organisations across Europe …
Biomarkers of Physical Frailty and Sarcopenia
Physical frailty and sarcopenia is a prototypical geriatric condition characterised by reduced physical function and low muscle mass. The multifaceted pathophysiology of this condition recapitulates all hallmarks of aging making specific biomarkers …
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
The COVID-19 pandemic places a lot of pressure on health-care systems. One of the components of decision-making for patients is whether they are frail or not. The COVID-19 in Older PEople (COPE) study is an initiative that aimes to deep-dive this issue …
COVID‐19: a major cause of cachexia and sarcopenia?
Coronavirus disease (COVID‐19) has reached pandemic proportions. Two animal studies have shown that coronavirus‐2 causes weight loss in animals associated with an increase in inflammatory cytokines. In humans, COVID‐19 causes anorexia, weight loss and low albumin. While poorly studied, this suggests that …
The dilemma of Coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science
An interesting article by Dr Majd AlGhatrif et al. in JAMA Cardiology, sheds light on the fact that the pandemic of Covid 19 presents a great challenge for the most vulnerable in general and the elderly in particular. Current available data …
Coronavirus crisis: insights from Switzerland
Data from various European countries confirm that while the whole population is at risk from infection with the coronavirus (SARS-CoV-2), older people – often frail and subject to multimorbidity – are at highest risk of intensive care hospitalisation for severe condition, and ultimately death.
Impact and lessons from the ‘Lifestyle Interventions and Independence for Elders’ (LIFE) clinical trials of physical activity to prevent mobility disability
Prof M. Pahor et al. led the Lifestyle Interventions and Independence for Elders (LIFE) studies aimed to evaluate if starting physical activity could prevent major mobility disability (MMD) in sedentary older adults …
Findings from The Copenhagen Sarcopenia Study: lean mass, strength, power and physical function in a Danish cohort aged 20–93 years
Low lean mass, muscle strength, and physical function are significant risk factors for disability, frailty, and mortality in older individuals …
Fall-Risk-Increasing Drugs: an European statement
The EuGMS (European Geriatric Medicine Society) Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs) state their position as to knowledge dissemination and management related to medication and its effects on falling. Knowledge is lacking among both physicians and older people, including caregivers, concerning the role of medication as a risk factor …
Looking for frailty in community-dwelling older persons: the Gérontopôle Frailty Screening Tool (GFST)
Identification of frail patients before their vulnerability is made evident by the onset of a major clinical event is one of the major challenges in implementing frailty into clinical practice. General practitioners play a key role in this context.
Due to an often busy practice, they need to be supported by screening tools, for example the provision of user-friendly and time-efficient ..
Latest Pubmed “frailty” article feed
- Frail People in LABLand: Development of an Easy-to-Use Machine Learning Model to Identify Frail People in Hospitals Based on Laboratory Data
- Supporting the frail elderly: from resilience to reducing hospitalizations
- Experience, facilitators, and barriers to the implementation of a multicomponent programme in older people living in the community, +AGIL Barcelona: A qualitative study
- Prediction of Nursing Home Admission Using the FRAIL-NH Scale Among Older Adults in Post-Acute Care Settings
Between a quarter and half of people older than 85 years are estimated to be frail, and these people have a substantially increased risk of falls, disability, long-term care, and death …
Read full >
The International Conference on Frailty and Sarcopenia Research
Toulouse, France 2023 details >
16th International SCWD Conference on Cachexia, Sarcopenia and Muscle Wasting
Full Stockholm Conference details >
Literature summaries >
Conference webcasts and video interviews.
Conference videos >
Popular slide sets covering the frailty syndrome. Free to use.
Powerpoints >
All Frailty.net website content and resources on implementing frailty into clinical practice.
How to implement frailty >